168 related articles for article (PubMed ID: 32888768)
1. How to capture activities of daily living in myotonic dystrophy type 2?
Montagnese F; Rastelli E; Stahl K; Massa R; Schoser B
Neuromuscul Disord; 2020 Oct; 30(10):796-806. PubMed ID: 32888768
[TBL] [Abstract][Full Text] [Related]
2. Validation of Motor Outcome Measures in Myotonic Dystrophy Type 2.
Montagnese F; Rastelli E; Khizanishvili N; Massa R; Stahl K; Schoser B
Front Neurol; 2020; 11():306. PubMed ID: 32373059
[No Abstract] [Full Text] [Related]
3. Review of patient-reported outcome measures for use in myotonic dystrophy type 1 patients.
Symonds T; Randall JA; Campbell P
Muscle Nerve; 2017 Jul; 56(1):86-92. PubMed ID: 27862031
[TBL] [Abstract][Full Text] [Related]
4. Rasch-built myotonic dystrophy type 1 activity and participation scale (DM1-Activ).
Hermans MC; Faber CG; De Baets MH; de Die-Smulders CE; Merkies IS
Neuromuscul Disord; 2010 May; 20(5):310-8. PubMed ID: 20363134
[TBL] [Abstract][Full Text] [Related]
5. Towards clinical outcome measures in myotonic dystrophy type 2: a systematic review.
Rastelli E; Montagnese F; Massa R; Schoser B
Curr Opin Neurol; 2018 Oct; 31(5):599-609. PubMed ID: 30048337
[TBL] [Abstract][Full Text] [Related]
6. Clinical Outcome Evaluations and CBT Response Prediction in Myotonic Dystrophy.
van As D; Okkersen K; Bassez G; Schoser B; Lochmüller H; Glennon JC; Knoop H; van Engelen BGM; 't Hoen PAC;
J Neuromuscul Dis; 2021; 8(6):1031-1046. PubMed ID: 34250945
[TBL] [Abstract][Full Text] [Related]
7. Severity, type, and distribution of myotonic discharges are different in type 1 and type 2 myotonic dystrophy.
Logigian EL; Ciafaloni E; Quinn LC; Dilek N; Pandya S; Moxley RT; Thornton CA
Muscle Nerve; 2007 Apr; 35(4):479-85. PubMed ID: 17230537
[TBL] [Abstract][Full Text] [Related]
8. Functional impairment in patients with myotonic dystrophy type 1 can be assessed by an ataxia rating scale (SARA).
DiPaolo G; Jimenez-Moreno C; Nikolenko N; Atalaia A; Monckton DG; Guglieri M; Lochmüller H
J Neurol; 2017 Apr; 264(4):701-708. PubMed ID: 28168524
[TBL] [Abstract][Full Text] [Related]
9. Change over time in ability to perform activities of daily living in myotonic dystrophy type 1.
Landfeldt E; Nikolenko N; Jimenez-Moreno C; Cumming S; Monckton DG; Faber CG; Merkies ISJ; Gorman G; Turner C; Lochmüller H
J Neurol; 2020 Nov; 267(11):3235-3242. PubMed ID: 32542526
[TBL] [Abstract][Full Text] [Related]
10. Reconstructing the Rasch-Built Myotonic Dystrophy Type 1 Activity and Participation Scale.
Hermans MC; Hoeijmakers JG; Faber CG; Merkies IS
PLoS One; 2015; 10(10):e0139944. PubMed ID: 26484877
[TBL] [Abstract][Full Text] [Related]
11. Cognitive behaviour therapy plus aerobic exercise training to increase activity in patients with myotonic dystrophy type 1 (DM1) compared to usual care (OPTIMISTIC): study protocol for randomised controlled trial.
van Engelen B;
Trials; 2015 May; 16():224. PubMed ID: 26002596
[TBL] [Abstract][Full Text] [Related]
12. Poor sleep quality and fatigue but no excessive daytime sleepiness in myotonic dystrophy type 2.
Tieleman AA; Knoop H; van de Logt AE; Bleijenberg G; van Engelen BG; Overeem S
J Neurol Neurosurg Psychiatry; 2010 Sep; 81(9):963-7. PubMed ID: 20798200
[TBL] [Abstract][Full Text] [Related]
13. Sleep disorders in myotonic dystrophy type 2: a controlled polysomnographic study and self-reported questionnaires.
Romigi A; Albanese M; Placidi F; Izzi F; Liguori C; Marciani MG; Mercuri NB; Terracciano C; Vitrani G; Petrucci A; Di Gioia B; Massa R
Eur J Neurol; 2014 Jun; 21(6):929-34. PubMed ID: 23837695
[TBL] [Abstract][Full Text] [Related]
14. Activities of daily living in myotonic dystrophy type 1.
Landfeldt E; Nikolenko N; Jimenez-Moreno C; Cumming S; Monckton DG; Faber CG; Merkies ISJ; Gorman G; Turner C; Lochmüller H
Acta Neurol Scand; 2020 May; 141(5):380-387. PubMed ID: 31889295
[TBL] [Abstract][Full Text] [Related]
15. Utility and Results from a Patient-Reported Online Survey in Myotonic Dystrophies Types 1 and 2.
Wenninger S; Stahl K; Montagnese F; Schoser B
Eur Neurol; 2020; 83(5):523-533. PubMed ID: 33120389
[TBL] [Abstract][Full Text] [Related]
16. The Myotonic Dystrophy Health Index: Italian validation of a disease-specific outcome measure.
Sansone VA; Lizio A; Greco L; Gragnano G; Zanolini A; Gualandris M; Iatomasi M; Heatwole C
Neuromuscul Disord; 2017 Nov; 27(11):1047-1053. PubMed ID: 28890289
[TBL] [Abstract][Full Text] [Related]
17. Quality of life in patients with myotonic dystrophy type 2.
Rakocevic Stojanovic V; Peric S; Paunic T; Pesovic J; Vujnic M; Peric M; Nikolic A; Lavrnic D; Savic Pavicevic D
J Neurol Sci; 2016 Jun; 365():158-61. PubMed ID: 27206898
[TBL] [Abstract][Full Text] [Related]
18. Quantitative myotonia assessment with a commercially available dynamometer in myotonic dystrophy types 1 and 2.
Horáková M; Horák T; Parmová O; Bednařík J; Voháňka S
Muscle Nerve; 2019 Apr; 59(4):431-435. PubMed ID: 30575988
[TBL] [Abstract][Full Text] [Related]
19. Myotonic dystrophy type 2 and modifier genes: an update on clinical and pathomolecular aspects.
Meola G; Cardani R
Neurol Sci; 2017 Apr; 38(4):535-546. PubMed ID: 28078562
[TBL] [Abstract][Full Text] [Related]
20. Fatigue and daytime sleepiness scale in myotonic dystrophy type 1.
Hermans MC; Merkies IS; Laberge L; Blom EW; Tennant A; Faber CG
Muscle Nerve; 2013 Jan; 47(1):89-95. PubMed ID: 23042586
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
